Emerging immunotherapies in older adults with acute myeloid leukemia

Por Vasu, Sumithira, Blum, William
Publicado em 2013

Targeted immunotherapy for acute myeloid leukemia

Por Vasu, Sumithira, Caligiuri, Michael A.
Publicado em 2011

The who, how and why: Allogeneic transplant for acute myeloid leukemia in patients older than 60 years

Por Wall, Sarah A., Devine, Steven, Vasu, Sumithira
Publicado no Blood Rev (2017)

Discharge disposition following hematopoietic cell transplantation: Predicting need for rehabilitation and association with survival

Por Wall, Sarah A., Zhao, Qiuhong, Vasu, Sumithira, Rosko, Ashley
Publicado no Transplant Cell Ther (2020)

A Novel Method to Expand Large Numbers of CD56(+)Natural Killer Cells from a Minute Fraction of Selectively Accessed Cryopreserved Cord Blood for Immunotherapy Post-transplantation

Por Vasu, Sumithira, Berg, Maria, Davidson-Moncada, Jan, Tian, Xin, Cullis, Herb, Childs, Richard W.
Publicado no Cytotherapy (2015)

Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic stem cell transplant relapse

Por Kent, Andrew, Vasu, Sumithira, Schatz, Derek, Monson, Natalie, Devine, Steven, Smith, Clayton, Gutman, Jonathan A., Pollyea, Daniel A.
Publicado no Blood Adv (2020)

FLT3L and Plerixafor Combination Increases Hematopoietic Stem Cell Mobilization and Leads to Improved Transplantation Outcome

Por He, Shun, Chu, Jianhong, Vasu, Sumithira, Deng, Youcai, Yuan, Shunzong, Zhang, Jianying, Fan, Zhijin, Hofmeister, Craig C., He, Xiaoming, Marsh, Henry C., Devine, Steven M., Yu, Jianhua
Publicado em 2013

Comparative analysis of antibiotic exposure association with clinical outcomes of chemotherapy versus immunotherapy across three tumour types

Por Kulkarni, Amit A, Ebadi, Maryam, Zhang, Shijia, Meybodi, Mohamad A, Ali, Alaa M, DeFor, Todd, Shanley, Ryan, Weisdorf, Daniel, Ryan, Charles, Vasu, Sumithira, Rashidi, Armin, Patel, Manish Ramesh
Publicado no ESMO Open (2020)

Long-term outcome of fludarabine-based reduced intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria

Por Pantin, Jeremy, Tian, Xin, Geller, Nancy, Ramos, Catalina, Cook, Lisa, Cho, Elena, Scheinberg, Phillip, Vasu, Sumithira, Khuu, Hahn, Stroncek, David, Barrett, John, Young, Neal S., Donohue, Theresa, Childs, Richard W.
Publicado em 2014

Midostaurin, Bortezomib and MEC in Relapsed/Refractory Acute Myeloid Leukemia

Por Walker, Alison R., Wang, Hongyan, Walsh, Katherine, Bhatnagar, Bhavana, Vasu, Sumithira, Garzon, Ramiro, Canning, Renee, Geyer, Susan, Wu, Yue-Zhong, Devine, Steven M., Klisovic, Rebecca, Blum, William, Marcucci, Guido
Publicado no Leuk Lymphoma (2016)

The Hematopoietic Stem Cell Transplant Comorbidity Index (HCT-CI) Can Predict for 30-Day Readmission Following Autologous Stem Cell Transplant for Lymphoma and Multiple Myeloma

Por Jaglowski, Samantha M., Ruppert, Amy S., Hofmeister, Craig C., Elder, Patrick, Blum, William, Klisovic, Rebecca, Vasu, Sumithira, Penza, Sam, Efebera, Yvonne A, Benson, Don M., Devine, Steven M., Andritsos, Leslie A
Publicado em 2014

Lower Dose of Antithymocyte Globulin (ATG) does not increase Graft-vs-Host Disease (GVHD) in Patients Undergoing Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Stem...

Por Salem, Galena, Ruppert, Amy S., Elder, Patrick, Hofmeister, Craig C., Benson, Don M., Penza, Sam, Andritsos, Leslie, Klisovic, Rebecca, Vasu, Sumithira, Blum, William, Devine, Steven M, Jaglowski, Samantha, Efebera, Yvonne A.
Publicado no Leuk Lymphoma (2014)

Polo-like kinase inhibitor volasertib marginally enhances the efficacy of the novel Fc-engineered anti-CD33 antibody BI 836858 in acute myeloid leukemia

Por Gopalakrishnan, Bhavani, Cheney, Carolyn, Mani, Rajeswaran, Mo, Xiaokui, Bucci, Donna, Walker, Alison, Klisovic, Rebecca, Bhatnagar, Bhavana, Walsh, Katherine, Rueter, Bjoern, Waizenegger, Irene C., Heider, Karl-Heinz, Blum, William, Vasu, Sumithira, Muthusamy, Natarajan
Publicado no Oncotarget (2018)

Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemia

Por Ranganathan, Parvathi, Yu, Xueyan, Santhanam, Ramasamy, Hofstetter, Jessica, Walker, Alison, Walsh, Katherine, Bhatnagar, Bhavana, Klisovic, Rebecca, Vasu, Sumithira, Phelps, Mitch A., Devine, Steven, Shacham, Sharon, Kauffman, Michael, Marcucci, Guido, Blum, William, Garzon, Ramiro
Publicado no Blood (2015)

A phase II multi-center study of the addition of azacitidine to reduced-intensity conditioning allogeneic transplantation for high-risk myelodysplasia (and older patients with acut...

Por Vij, Ravi, Le-Rademacher, Jennifer, Laumann, Kristina, Hars, Vera, Owzar, Kouros, Shore, Tsiporah, Vasu, Sumithira, Cashen, Amanda, Isola, Luis, Shea, Thomas, DeMagalhaes-Silverman, Margarida, Hurd, David, Meehan, Kenneth, Beardell, Frank, Devine, Steven
Publicado no Biol Blood Marrow Transplant (2019)

Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AML

Por Jeon, Jae Yoon, Zhao, Qiuhong, Buelow, Daelynn R., Phelps, Mitch, Walker, Alison R., Mims, Alice S., Vasu, Sumithira, Behbehani, Gregory, Blachly, James, Blum, William, Klisovic, Rebecca B., Byrd, John C., Garzon, Ramiro, Baker, Sharyn D., Bhatnagar, Bhavana
Publicado no Invest New Drugs (2019)

Selinexor in Combination with Decitabine in Patients with Acute Myeloid Leukemia: Results from a Phase 1 study

Por Bhatnagar, Bhavana, Zhao, Qiuhong, Mims, Alice S., Vasu, Sumithira, Behbehani, Gregory K., Larkin, Karilyn, Blachly, James S., Blum, William, Klisovic, Rebecca B., Ruppert, Amy S., Orwick, Shelley, Oakes, Christopher, Ranganathan, Parvathi, Byrd, John C., Walker, Alison R., Garzon, Ramiro
Publicado no Leuk Lymphoma (2019)

Comparison of Fixed Dose Reduced-Intensity Conditioning with Fludarabine and Busulfan to PK-guided Busulfan AUC (FluBu4K) in Hematopoietic Stem Cell Transplant for AML/MDS

Por Rasor, Brendan, Dickerson, Tyler, Zhao, Qiuhong, Elder, Patrick, Brammer, Jonathan E, Larkin, Karilyn, Jaglowski, Samantha, Mims, Alice, Penza, Sam, Vasu, Sumithira, Wall, Sarah A, William, Basem, Saad, Ayman, Roddy, Julianna V.F., Choe, Hannah, Puto, Marcin
Publicado no Leuk Lymphoma (2020)

Tocilizumab for steroid refractory acute graft-versus-host disease

Por Roddy, Julianna V. F., Haverkos, Bradley M., McBride, Ali, Leininger, Kathryn M., Jaglowski, Samantha, Penza, Sam, Klisovic, Rebecca, Blum, William, Vasu, Sumithira, Hofmeister, Craig C., Benson, Don M., Andritsos, Leslie A., Devine, Steven M., Efebera, Yvonne A.
Publicado no Leuk Lymphoma (2015)

Anti-leukemic effects of all-trans retinoic acid in combination with Daratumumab in acute myeloid leukemia

Por Buteyn, Nathaniel J, Fatehchand, Kavin, Santhanam, Ramasamy, Fang, Huiqing, Dettorre, Gino M, Gautam, Shalini, Harrington, Bonnie K, Henderson, Sally E, Merchand-Reyes, Giovanna, Mo, Xiaokui, Benson, Don M, Carson, William E, Vasu, Sumithira, Byrd, John C, Butchar, Jonathan P, Tridandapani, Susheela
Publicado no Int Immunol (2018)